Metastatic Melanoma with Jason Luke, MD and Jeffrey Weber, MD, PhD
EP. 1: Jason Luke, MD: Factors to Consider When Determining Treatment
Watch
EP. 2: Jeffrey Weber, MD, PhD: Factors to Consider When Determining Treatment
EP. 3: Jeffrey Weber, MD, PhD: The Impact of Moderate Level of Disease Burden on Response to Targeted Therapy
EP. 4: Jason Luke, MD: The Impact of Moderate Level of Disease Burden on Response to Targeted Therapy
EP. 5: Jeffrey Weber, MD, PhD: Durability of a Response to Targeted Therapy Combination
EP. 6: Jason Luke, MD: Durability of a Response to Targeted Therapy Combination
EP. 7: Jeffrey Weber, MD, PhD: The Impact of BRAF/MEK Inhibitors in Melanoma
EP. 8: Jeffrey Weber, MD, PhD: Second-Line Therapy
EP. 9: Jason Luke, MD: The Impact of BRAF/MEK Inhibitors in Melanoma
EP. 10: Jason Luke, MD: Second-Line Therapy
